

IP79: Prostate Cancer: Localized: Surgical Therapy IV
Monday, May 18, 2026 9:30 AM to 11:30 AM · 2 hr. (America/New_York)
145AB
Poster and Podium Sessions
Oncology: Prostate
Speakers

David Lee
Professor of Urology, University of California IrvineUniversity of California Irvine
Sanjay Razdan
MD, MChInternational Robotic Institute for Prostate Cancer
Joseph Wagner
Chief of Urology, Hartford Hospital and Director of Robotic Surgery, Hartford HealthCareHartford HealthCare/University of ConnecticutMonday, May 18
IP79-01: PI-RADS–Stratified MRI PSA Density and Adverse Pathology after Radical Prostatectomy in the MRI Era
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
Hangcheng Fu · University Of Louisville
IP79-02: Patient Regret Following Focal Therapy vs Radical Prostatectomy for Prostate Cancer
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
Kalli Mulholland · University of Michigan Medical School
IP79-03: Predicting Post-Prostatectomy Quality of Life: Machine Learning Models for Enhanced Patient-Centered Decision-Making
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
Zhiyu (jason) Qian · Brigham and Women's Hospital
IP79-04: The Impact of Different Robotic Platforms on Functional and Oncological outcomes in patients treated with Retzius-sparing Robotic Radical Prostatectomy
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
Alberto Quistini
IP79-05: Association between perineural invasion and increased risk of castration-resistant prostate cancer
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
Xuedong Wei · Department of Urology at the First Affiliated Hospital of Soochow University
IP79-06: Comparative Perioperative Outcomes of Extended Versus Limited Pelvic Lymph Node Dissection in Radical Prostatectomy for Intermediate- and High-Risk Prostate Cancer: A Phase III Randomized Trial
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
Matheus Ruggeri · University of São Paulo
IP79-07: Enhanced Optical Zoom and Camera Efficiency in da Vinci Xi versus da Vinci 5 for Radical Prostatectomy: Impact on Surgical Workflow and Efficiency
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
Deerush Kannan Sakthivel · Miami Cancer Institute, Baptist Health South Florida
IP79-08: THE MIAMI CANCER INSTITUTE TECHNIQUE: PUBOPROSTATIC LIGAMENT PRESERVATION WITH SELECTIVE DORSAL VENOUS COMPLEX LIGATION AND CYSTOURETHROPEXY
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
Deerush Kannan Sakthivel · Miami Cancer Institute, Baptist Health South Florida
IP79-09: Dehydrated Human Amniotic Membrane for Early Return of Erectile Function After Robotic Radical Prostatectomy: A 10-Year Journey and Lessons Learned
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
Shirin Razdan · Miami Robotic Surgery
IP79-10: Managing Robotic Radical Prostatectomy in Men with Penile Prosthesis: Surgical Technique and Outcomes
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
Rohan Sharma · Advent health Global Robotics Institute
IP79-11: Comparative Trifecta Outcomes Following Radical Prostatectomy versus Focal Therapy for Localized Prostate Cancer: Functional and Oncologic Trade-offs in a Contemporary Cohort
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
Braian Ledesma
IP79-12: Improved Sexual Function in Older Men Undergoing Posterior Approach to Endopelvic Neurovascular Total Sparing (PATENTS) Radical Prostatectomy
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
Gal Wald · NYP/Weill Cornell
IP79-13: Comparison of Anastomotic Strictures by Retzius-Sparing vs. Anterior Approach Robotic-Assisted Radical Prostatectomy
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
Kyle Blum
IP79-14: Recurrence Patterns After Deferred Treatment in Biochemically Recurrent Prostate Cancer Following a Negative PSMA PET/CT
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
Maya Ataya · Indiana University
IP79-15: Are Prebiopsy PI-RADS 5 Lesions Associated With Pathologic Upgrade after Robot-Assisted Radical Prostatectomy in Gleason Grade Group 2 Prostate Cancer?
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
Moayid Fallatah
IP79-16: Beyond continence control: a systematic review and meta-analysis of oncological outcomes in prostate cancer patients undergoing Retzius-sparing robot-assisted radical prostatectomy versus conventional robot-assisted radical prostatectomy
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
Katie Du
IP79-17: Opioid-free single-port robot-assisted radical prostatectomy under subarachnoid anesthesia: feasibility from the initial experience
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
Michele Marchioni
IP79-18: Impact of Gleason grading on survival outcomes in patients with low loco-regional lymphogenic metastatic burden at radical prostatectomy
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
Elena Berg
IP79-19: Development of Histologic Criteria for Objective Evaluation of The Quality of Nerve Sparing during Robot-Assisted Radical Prostatectomy
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
Ahmed Hussein
IP79-20: Robot-assisted prostatectomy associated with 3D reconstruction for trifecta outcomes
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
Nilo Barretto · Hospita Mater Dei Salvador
IP79-21: Does obesity lead to higher positive surgical margins in patients undergoing robotic-assisted radical prostatectomy for non-metastatic prostate cancer? A propensity score matched analysis
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
Sai Kalpitha Eragamreddy
IP79-22: Real Time Digital Pathology with 3D Augmented Reality guidance during RARP
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
Enrico Checcucci
IP79-23: Comparative Outcomes of Salvage Robotic Radical Prostatectomy After Radiation Therapy Versus Focal Therapy: A Systematic Review and Meta-Analysis
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
Marco Antonio Andrade Junior · Federal University of Minas Gerais
IP79-24: Predicting Pathological Upstaging in Prostate Cancer: An Artificial Neural Network Integrating PSMA PET, PSA, and MRI in a South Asian Cohort
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
Nisanth Puliyath · Calicut Medical College, India
IP79-25: Extraperitoneal Robot-Assisted Radical Prostatectomy with the Hugo™ RAS System: 100 consecutive cases, 1-year follow-up and surgical learning curve evaluation
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
Giovanni Filomena
IP79-26: Impact of learning curve on perioperative and pathologic outcomes of single port robotic radical prostatectomy: results from a high-volume center
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
Gabriele Tuderti · "Regina Elena" National Cancer Institute, Dept. of
IP79-27: Artificial intelligence–driven objective assessment of neurovascular bundle preservation predicts urinary continence recovery after robot-assisted radical prostatectomy
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
Satoshi Ando · Reprocare Clinic Otakanomori
IP79-28: Development of a Preoperative Nomogram to Predict PSA Persistence After Robot-Assisted Radical Prostatectomy
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
Yu Ozawa · AdventHealth Global Robotics Institute
IP79-29: Single Port Robotic Radical Prostatectomy in Septuagenarian Patients
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
Samarpit Rai · Cleveland Clinic
IP79-30: Total en-bloc urethra preservation at robot-assisted prostatectomy (ToP-RAP): a prospective IDEAL stage I–IIa study
Monday, May 18, 2026 9:30 AM to 11:30 AM
145AB
Sami-Ramzi Leyh-Bannurah · Urology, Pediatric Urology and Urologic Oncology,
